TFA
WST icon

Toth Financial Advisory’s West Pharmaceutical WST Stock Holding History

Toth Financial Advisory’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.11K Buy
+3
New +$1.06K ﹤0.01% 930
2024
Q1 		– Sell
-11
Closed -$3.87K – 778
2023
Q4 		$3.87K Hold
11
– – ﹤0.01% 556
2023
Q3 		$4.13K Buy
+11
New +$4.25K ﹤0.01% 556
2023
Q2 		– Sell
-2
Closed -$693 – 902
2023
Q1 		$693 Buy
+2
New +$584 ﹤0.01% 766

Other funds holding WST

BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
BWM
Biltmore Wealth Management Tempe, Arizona $323M AUM 13.82% 1-Year Est. Return
RFA
RTD Financial Advisors Philadelphia, Pennsylvania $914M AUM 11.18% 1-Year Est. Return

Toth Financial Advisory's WST Position: Q3 2026 in Review

Toth Financial Advisory opened a new position in West Pharmaceutical (WST) in Q3 2026: 3 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #930 among its holdings. This is a return to the name: Toth Financial Advisory previously reported a position in WST as recently as Q4 2023.

Toth Financial Advisory first reported a position in WST in Q1 2023 and has held it in 4 quarters since. The position peaked at $4.13K in Q3 2023. 29 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Toth Financial Advisory held 3 shares of West Pharmaceutical worth $1.11K as of Q3 2026.
  • West Pharmaceutical was a new Toth Financial Advisory position in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #930 holding.
  • Toth Financial Advisory first reported a position in West Pharmaceutical in Q1 2023 and has held it in 4 quarters since.
  • Toth Financial Advisory's West Pharmaceutical position peaked at $4.13K in Q3 2023.
  • 29 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.